Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

Turning AI challenges into real effects – together

How we can transform complex challenges in healthcare and pharmaceuticals into real impact through responsible AI, strong collaboration, and digital leadership.

The Great Rewiring: A Look Back

What became apparent in Davos was that AI moved from aspiration to implementation and began to reorganize decisions, systems, and leadership in various industries.

Article

From Data to Impact - How industrial companies create real added value with AI

Solve production problems faster and increase efficiency with a clear data strategy and targeted use of AI

Article

The Great Rewiring: A Look Back

What became apparent in Davos was that AI moved from aspiration to implementation and began to reorganize decisions, systems, and leadership in various industries.

Article

Turning AI challenges into real effects – together

How we can transform complex challenges in healthcare and pharmaceuticals into real impact through responsible AI, strong collaboration, and digital leadership.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.